DOSSIER · 13F Holders · Q3 2026
TVTX 2.25 03/01/29
Travere Therapeutics Inc.
14 institutions still hold Travere Therapeutics Inc. as of Q3 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 89422GAA5·14 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q3 2026
14 institutions reported TVTX 2.25 03/01/29 in Q3 2026. TENOR CAPITAL MANAGEMENT Co., L.P. leads at 43.0% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.